Volterra Technologies’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$733K Buy
+25,700
New +$684K 0.17% 132
2025
Q3
– Sell
-308,500
Closed -$7.48M – 513
2025
Q2
$7.48M Buy
+308,500
New +$7.19M 0.95% 18

Other funds holding PFE

Volterra Technologies's PFE Position: Q3 2026 in Review

Volterra Technologies reduced its Pfizer (PFE) stake by 61% in Q3 2026, selling an estimated $679K and leaving 16,404 shares worth $468K. The position accounts for 0.11% of the portfolio, ranked #188.

Volterra Technologies first reported a position in PFE in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.01M in Q2 2026. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Volterra Technologies held 16,404 shares of Pfizer worth $468K as of Q3 2026.
  • Volterra Technologies sold 25,534 Pfizer shares in Q3 2026, an estimated $679K.
  • Pfizer made up 0.11% of Volterra Technologies's portfolio in Q3 2026, its #188 holding.
  • Volterra Technologies first reported a position in Pfizer in Q1 2026 and has held it in 3 quarters since.
  • Volterra Technologies's Pfizer position peaked at $1.01M in Q2 2026.
  • 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Volterra Technologies's 13F filing for Q3 2026, filed 16 Nov 2026.